Dx Digest: What's Next for This Trusted IVD Manufacturer?
Featuring CEO & Co-Founder of FlexMedical Solutions, Kevin Fallon.
Featuring CEO & Co-Founder of FlexMedical Solutions, Kevin Fallon.
Innovation in cellular biology and proteomics diagnostic spaces has advanced significantly in recent years. Here, I take a look at some of the most impressive companies in the space. Click to see who I feature.
Featuring CEO & Co-Founder of FlexMedical Solutions, Kevin Fallon.
Innovation in cellular biology and proteomics diagnostic spaces has advanced significantly in recent years. Here, I take a look at some of the most impressive companies in the space. Click to see who I feature.
How are strides in the agrigenomics space helping climate and business thrive in 2023? Let’s take a look.
As spatial biology technology reaches new heights, leading companies in the space are creating revolutionary new solutions. Who should we be watching in 2023? Click here to find out.
In this live webinar, I welcomed two esteemed guests with over 20 years combined experience in corporate development to break down strategies and processes and discuss their insights. Click to watch the full recording.
In this episode, we speak with Erez Naaman, Co-Founder & CTO at Scopio Labs, about what to introduction of AI means for the future of the diagnostics market.
In this episode, Nathan speaks with Richard Acton, former CSO at Cignpost Diagnostics, about transitioning a company from a COVID testing business to a health and wellness business.
In this episode I invite Co-Founder and Chief Lab & Innovation Officer at MySimplePetLab, Dennis Chmiel to chat about all things expansion in this ever-growing market. Click to listen to the full episode now.
When it comes to recruitment, what are the real insider hacks you need to know? From onboarding to retention, I'm keen to share a few things I've learned...
Pet care has significantly advanced in recent years, most notably in the wearable veterinary diagnostics niche. I'm keen to explore the progress of the sector’s innovators and what this means for the market.
The animal health market has seen considerable growth in recent months, with these exciting trends welcoming opportunities for a number of start-ups to bring innovative product offerings to market. Click to find out who.
Recruiter conferences are rich opportunities to learn and develop, but what are the key benefits to prepare for before you attend? Let’s break it down.
In an ever-changing industry, how can cell and gene therapy start-ups remain dynamic to new challenges to not only survive coming changes but thrive? Click to read more.
How is AI affecting drug discovery, and what does the future hold? We explored the future trajectory of AI and found some promising start-ups on the horizon.
In a space of increased innovation in drug delivery, I took a deeper look into the leading products taking the market by storm.
In this episode of Diagnostics Digest, I speak with David Wells, Chief Executive Officer of the Institute of Biomedical Science (IBMS) and Chief NHS Pathologist during COVID-19. Click to listen now.
In this episode, I speak to Leigh Fell, CEO at Caritas Neuro Solutions, about carving your niche, the impact of work-life balance, the importance of psychedelic drug discovery and loads more. Click here to listen.
How can we improve diversity and access within the research space, particularly at site level? We asked some site managers in the know.
Are you attracting the very best industry talent to your start-up? For expert advice on how to thrive in today’s life science talent market, watch CM Life Science's latest 30-minute webinar. Click to watch.
In this episode of Diagnostics Digest, a CM Life Science series discussing trends and insights into the diagnostics market, I speak with Beth Cobb, Chief Operating Officer at NOWDiagnostics | NowDx.
In this episode, I speak with Kirk Sudheimer, SVP of BD & Sales at Health Catalyst about collaboration, innovation and transforming the future of healthcare. Click and have a listen.
In this episode, I chat with Grant Neckermann, SVP of Talent at Syapse, about leading an innovative start-up to success through investment in people. Click to hear his thoughts.
In this episode of Lessons from Leaders in Life Science, I spoke with Jen Skeen, COO at renegade.bio, about carving your own path as a woman in science and so much more. Check out her brilliant story.
The data revolution has created a wealth of opportunity in the bioinformatics industry. I caught up with three industry experts to find out what's next for software data in the life sciences industry. Click to find out who.
In this episode of CM Conversations, I speak with Dr. Callie Seaman, company Director, trained medical professional, and experienced medicinal cannabis advocate about the future of the industry in the UK. Click to have a listen.
How have animal diagnostics companies adapted to stay relevant and successful post-pandemic? We explore companies across the industry to find out.
We spoke to Margaret, Chris, Tiffany and Brad about the challenge clinical trials have in becoming more heterogeneous
First, it's one of Boston's 'Best Small Companies To Work For', then it announced a major Labcorp partnership. But how have Weavr Health overcome the challenges of retaining a core company culture when scaling a fast-growing start-up?
Developing and manufacturing drugs is more expensive and complicated than ever before. Many outsource to CDMO's, but which approach truly offers the most value? Click to read more.
Small molecules are now able to target previously ‘undruggable’ conditions, such as cancers and neurological disorders, I discuss how we got here and what it means for the market. Click to read more.